Related references
Note: Only part of the references are listed.Blocking the CD47-SIRP alpha axis by delivery of anti-CD47 antibody induces antitumor effects in glioma and glioma stem cells
Feng Li et al.
ONCOIMMUNOLOGY (2018)
Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells
Yu Shi et al.
CELL DEATH AND DIFFERENTIATION (2017)
Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells
Hengqiang Zhao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
Purine synthesis promotes maintenance of brain tumor initiating cells in glioma
Xiuxing Wang et al.
NATURE NEUROSCIENCE (2017)
Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells
N. Sumru Bayin et al.
ONCOTARGET (2017)
Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties
Atreyi Dasgupta et al.
ONCOTARGET (2017)
The Regulation and Function of Lactate Dehydrogenase A: Therapeutic Potential in Brain Tumor
Cara J. Valvona et al.
BRAIN PATHOLOGY (2016)
VDAC2-specific cellular functions and the underlying structure
Shamim Naghdi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth
Baoli Hu et al.
CELL (2016)
MYBL2 guides autophagy suppressor VDAC2 in the developing ovary to inhibit autophagy through a complex of VDAC2-BECN1-BCL2L1 in mammals
Jia Yuan et al.
AUTOPHAGY (2015)
The mitochondrial voltage-dependent anion channel 1 in tumor cells
Varda Shoshan-Barmatz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
The proteomic 2D-DIGE approach reveals the protein voltage-dependent anion channel 2 as a potential therapeutic target in epithelial thyroid tumours
Eugenia Mato et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations
Bradley A. Webb et al.
NATURE (2015)
Mitochondrial control by DRP1 in brain tumor initiating cells
Qi Xie et al.
NATURE NEUROSCIENCE (2015)
Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma
Yao-An Shen et al.
CELL CYCLE (2015)
Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2
Z. Wang et al.
ONCOGENE (2015)
Comprehensive Analysis of Glycolytic Enzymes as Therapeutic Targets in the Treatment of Glioblastoma
Morgane Sanzey et al.
PLOS ONE (2015)
Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells
Keita Shibuya et al.
ONCOTARGET (2015)
Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway
P-P Liu et al.
CELL DEATH AND DIFFERENTIATION (2014)
Energy Metabolism Characterization of a Novel Cancer Stem Cell-Like Line 3AB-OS
Roberta Palorini et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
Jianqun Liao et al.
PLOS ONE (2014)
Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance
P. Dahan et al.
CELL DEATH & DISEASE (2014)
Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment
D. Ciavardelli et al.
CELL DEATH & DISEASE (2014)
Glioblastoma and Other Malignant Gliomas A Clinical Review
Antonio Omuro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
The secretome of colon cancer stem cells contains drug-metabolizing enzymes
Benjamin L. Emmink et al.
JOURNAL OF PROTEOMICS (2013)
Tumor glycolysis as a target for cancer therapy: progress and prospects
Shanmugasundaram Ganapathy-Kanniappan et al.
MOLECULAR CANCER (2013)
Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake
William A. Flavahan et al.
NATURE NEUROSCIENCE (2013)
Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3
Ping Mao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
VDAC structure, selectivity, and dynamics
Marco Colombini
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2012)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells
Jian Chen et al.
CELL (2012)
Disruption of the VDAC2-Bak interaction by Bcl-xS mediates efficient induction of apoptosis in melanoma cells
M. Ploetz et al.
CELL DEATH AND DIFFERENTIATION (2012)
Moving toward molecular classification of diffuse gliomas in adults
Brett J. Theeler et al.
NEUROLOGY (2012)
Kruppel-like Factor 4 (KLF4) Activates the Transcription of the Gene for the Platelet Isoform of Phosphofructokinase (PFKP) in Breast Cancer
Jong-Seok Moon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Metabolic Alterations in Highly Tumorigenic Glioblastoma Cells PREFERENCE FOR HYPOXIA AND HIGH DEPENDENCY ON GLYCOLYSIS
Yunfei Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Posttranslational Modification of 6-phosphofructo-1-kinase as an Important Feature of Cancer Metabolism
Andreja Smerc et al.
PLOS ONE (2011)
Metabolic state of glioma stem cells and nontumorigenic cells
Erina Vlashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells
Benjamin Kefas et al.
NEURO-ONCOLOGY (2010)
Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma
Shu Diao et al.
PROTEOMICS (2010)
Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
Zhizhong Li et al.
CANCER CELL (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling
Hye-Min Jeon et al.
GENES & DEVELOPMENT (2008)
Stem cell-related Self-Renewal signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
Anastasia Murat et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Expression of stem cell markers in human astrocytomas of different WHO grades
Yue-Hui Ma et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Modulation of mitochondrial membrane permeability in pathogenesis, autophagy and control of metabolism
John J. Lemasters
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor
Shideng Bao et al.
CANCER RESEARCH (2006)
Chemotherapy resistance of glioblastoma stem cells
A. Eramo et al.
CELL DEATH AND DIFFERENTIATION (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
In self-defence: Hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death
H Azoulay-Zohar et al.
BIOCHEMICAL JOURNAL (2004)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
VDAC: The channel at the interface between mitochondria and the cytosol
M Colombini
MOLECULAR AND CELLULAR BIOCHEMISTRY (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
VDAC2 inhibits BAK activation and mitochondrial apoptosis
EHY Cheng et al.
SCIENCE (2003)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Share Paper
